Lv1
10 积分 2024-08-06 加入
P2X3-Receptor Antagonists as Potential Antitussives: Summary of Current Clinical Trials in Chronic Cough
1个月前
已完结
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
1个月前
已完结
P2X3 receptor antagonists for the treatment of chronic cough
1个月前
已关闭
皖公网安备34019202002308
